ANNA STAUB: Open Payments
NPI 1952072811 · LOS ALTOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,597 in 73 payments from 16 companies in 2025. Trend: 2023 $3,380 · 2024 $4,680 · 2025 $2,597
Food & beverage: $2,597
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $430 |
| Organon LLC | 4 | $353 |
| Novartis Pharmaceuticals Corporation | 8 | $235 |
| Galderma Laboratories, L.P. | 5 | $214 |
| Arcutis Biotherapeutics, Inc. | 6 | $202 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $191 |
| Incyte Corporation | 6 | $152 |
| GENZYME CORPORATION | 5 | $142 |
| UCB, Inc. | 4 | $130 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
Products named: VTAMA, DUPIXENT, BOTOX, Zoryve, Winlevi, NEMLUVIO, OPZELURA, Bimzelx.
Industry payments across CA — which companies pay providers there.
